balstilimab

Generic: Balstilimab

balstilimab: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.

Development Pipeline (1)

Clinical Trials (1)

Phase 2 Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

NCT05928806·Phase 2·AGEN
Suspended

Frequently asked questions

Who is developing balstilimab?

balstilimab is being developed by AGENUS INC.

How many clinical trials involve balstilimab?

BioSniper tracks 1 clinical trial involving balstilimab.

Get deeper analysis on balstilimab

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    balstilimab — Drug Pipeline, Trials & FDA Status | BioSniper